Use of whole genome sequencing to identify low-frequency mutations in COVID-19 patients treated with remdesivir
View ORCID ProfileKuganya Nirmalarajah, View ORCID ProfileFinlay Maguire, Winfield Yim, View ORCID ProfilePatryk Aftanas, Angel X. Li, Altynay Shigayeva, Lily Yip, Xi Zoe Zhong, View ORCID ProfileAllison J. McGeer, View ORCID ProfileSamira Muberka, View ORCID ProfileRobert Kozak
doi: https://doi.org/10.1101/2022.11.20.22282552
Kuganya Nirmalarajah
1Sunnybrook Research Institute, Toronto, Ontario, M4N 3M5, Canada
2Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, M5S 1A8, Canada
Finlay Maguire
3Faculty of Computer Science, Dalhousie University, Halifax, Nova Scotia, B3H 4R2, Canada
4Department of Community Health & Epidemiology, Dalhousie University, Halifax, Nova Scotia, B3H 4R2, Canada
Winfield Yim
1Sunnybrook Research Institute, Toronto, Ontario, M4N 3M5, Canada
Patryk Aftanas
5Shared Hospital Laboratory, Toronto, Ontario, M4N 3M5, Canada
Angel X. Li
6Sinai Health System, Toronto, Ontario, M5G 1X5, Canada
Altynay Shigayeva
6Sinai Health System, Toronto, Ontario, M5G 1X5, Canada
Lily Yip
1Sunnybrook Research Institute, Toronto, Ontario, M4N 3M5, Canada
Xi Zoe Zhong
6Sinai Health System, Toronto, Ontario, M5G 1X5, Canada
Allison J. McGeer
2Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, M5S 1A8, Canada
6Sinai Health System, Toronto, Ontario, M5G 1X5, Canada
Samira Muberka
1Sunnybrook Research Institute, Toronto, Ontario, M4N 3M5, Canada
2Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, M5S 1A8, Canada
Robert Kozak
1Sunnybrook Research Institute, Toronto, Ontario, M4N 3M5, Canada
2Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, M5S 1A8, Canada
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted November 22, 2022.
Use of whole genome sequencing to identify low-frequency mutations in COVID-19 patients treated with remdesivir
Kuganya Nirmalarajah, Finlay Maguire, Winfield Yim, Patryk Aftanas, Angel X. Li, Altynay Shigayeva, Lily Yip, Xi Zoe Zhong, Allison J. McGeer, Samira Muberka, Robert Kozak
medRxiv 2022.11.20.22282552; doi: https://doi.org/10.1101/2022.11.20.22282552
Use of whole genome sequencing to identify low-frequency mutations in COVID-19 patients treated with remdesivir
Kuganya Nirmalarajah, Finlay Maguire, Winfield Yim, Patryk Aftanas, Angel X. Li, Altynay Shigayeva, Lily Yip, Xi Zoe Zhong, Allison J. McGeer, Samira Muberka, Robert Kozak
medRxiv 2022.11.20.22282552; doi: https://doi.org/10.1101/2022.11.20.22282552
Subject Area
Subject Areas
- Addiction Medicine (357)
- Allergy and Immunology (680)
- Anesthesia (182)
- Cardiovascular Medicine (2693)
- Dermatology (229)
- Emergency Medicine (405)
- Epidemiology (12330)
- Forensic Medicine (10)
- Gastroenterology (772)
- Genetic and Genomic Medicine (4166)
- Geriatric Medicine (392)
- Health Economics (689)
- Health Informatics (2703)
- Health Policy (1010)
- Hematology (366)
- HIV/AIDS (864)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (446)
- Neurology (3949)
- Nursing (214)
- Nutrition (587)
- Oncology (2083)
- Ophthalmology (596)
- Orthopedics (245)
- Otolaryngology (308)
- Pain Medicine (253)
- Palliative Medicine (75)
- Pathology (474)
- Pediatrics (1134)
- Primary Care Research (462)
- Public and Global Health (6591)
- Radiology and Imaging (1429)
- Respiratory Medicine (879)
- Rheumatology (415)
- Sports Medicine (345)
- Surgery (456)
- Toxicology (55)
- Transplantation (191)
- Urology (170)